NCT00399048: An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release) |
|
|
| Completed | 3 | 140 | US | OROS hydromorphone HCL ; OxyContin | Alza Corporation, DE, USA | Osteoarthritis, Knee, Osteoarthritis, Hip | | 05/01 | | |
NCT00361504: A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain |
|
|
| Completed | 3 | 1123 | US, Canada | Oxycodone CR, Tapentadol (CG5503) ER, CG5503 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Grünenthal GmbH | Osteoarthritis, Hip, Osteoarthritis, Knee, Lower Back Pain, Pain | 07/08 | 07/08 | | |
